This archived content created prior to April 24, 2026 is being made available for reference, research, or recordkeeping purposes only and may not meet current web content accessibility standards. If required, an accessible version of this content can be made on request.
University of Hawaiʻi Cancer Center researchers, S. Lani Park, MPH, PhD, and Lenora Loo, PhD, were awarded a five-year $2.8 million grant from the National Institute on Minority Health and Health Disparities (NIMHD) of the National Institutes of Health , to study smoking-related lung cancer disparities across different racial and ethnic populations.

"This is the first study of its kind to molecularly characterize smoking-related lung cancer across different racial and ethnic groups. Lung tumor biology may be a key contributor to the disparities in lung cancer risk and survival," said Park, study co-principal investigator and UH Cancer Center associate researcher.
Park and Loo will use data and biospecimens from the Multiethnic Cohort (MEC) Study to characterize the molecular profiles such as DNA methylation and gene expression of lung adenocarcinoma, the most common subtype of lung cancer, from different racial and ethnic groups. The racial and ethnic populations being studied include African Americans, Japanese Americans, Latinos, Native Hawaiians and Whites.
Previous findings showed that even after accounting for known lung cancer risk factors, such as smoking history, Native Hawaiians and African Americans are at greater risk of disease compared to Whites. Japanese Americans and Latinos were found to have a lower risk of lung cancer compared to any of the above three studied populations. Moreover, survival across the five populations are not equal.
"We hope that the findings from this study will provide new information on the biological mechanisms that contribute to the racial and ethnic disparities of lung cancer, so that new personalized treatment targets and strategies can be developed to mitigate these disparities," said Loo, study co-principal investigator and UH Cancer Center associate researcher.
UH Cancer Center Hawaiʻi Tumor Registry
1R01MD014862-01
###
About the University of Hawaiʻi Cancer Center
The University of Hawaiʻi Cancer Center is dedicated to saving lives in Hawaiʻi and the Pacific, and inspiring hope by working to conquer cancer. The flagship priority is to understand and address cancer health disparities. The center strives to achieve this through research, education, patient care, and community outreach, focusing on the unique and diverse ethnic, cultural, and environmental characteristics of Hawaiʻi and the Pacific.
The UH Cancer Center is one of only 74 institutions designated by the National Cancer Institute (NCI), representing a significant mark of excellence, and is the only NCI-designated cancer center in Hawaiʻi and the Pacific. The center contributes more than $57 million to Hawaiʻi's economy through scientific research, clinical trials, and other activities.
As part of the University of Hawaiʻi at Mānoa, the UH Cancer Center operates out of facilities located in Kakaʻako. The center directly employs more than 300 faculty and staff, with an additional 200 affiliate members and cooperative agreements with organizations that are part of the Hawaiʻi Cancer Consortium. The consortium includes The Queen’s Health Systems, Hawaiʻi Pacific Health, Kuakini Medical Center, Adventist Health Castle, Hawaiʻi Medical Service Association (HMSA), and the John A. Burns School of Medicine (JABSOM), all working together with the UH Cancer Center to advance cancer research and treatment in the state.
Learn more at https://www.uhcancercenter.org | Connect with us on Facebook | Instagram | X | LinkedIn